Sign up to save your podcasts
Or
Share JAMA Oncology : Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening
Interview with Nora Pashayan, BSc MSc MSt MD PhD FFPH, author of Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Nora Pashayan, BSc MSc MSt MD PhD FFPH, author of Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
More shows like JAMA Network
View all
JAMA Editors' Summary
139 Listeners
NEJM This Week
319 Listeners
AFP: American Family Physician Podcast
698 Listeners
JAMA Clinical Reviews
499 Listeners
Medicine and Science from The BMJ
36 Listeners
Diabetes Core Update
102 Listeners
Mayo Clinic Talks
291 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Neurology Author Interviews
12 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
6 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
91 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
The Curious Clinicians
372 Listeners
NEJM AI Grand Rounds
56 Listeners